Drugs (2019) 79(16):174155
So, OK, all the compounds in those drugs you just mentioned were, initially, approved to treat diabetes
Activates GLP-1 receptors for appetite suppression, gastric emptying delay, and glucose homeostasis
CJC-1295 has several modifications for improved pharmacokinetics, including the substitution of four amino acids in the original 29 amino acid chain, which improves the peptides stability and effectiveness [4, 5, 6]: At the second position, L-alanine is replaced with D-alanine, heightening resistance to the enzyme dipeptidyl peptidase-4 (DPP-4), which plays a crucial role in deactivating many peptide-based medications
The answer is more complicated than many headlines suggest